Webinars

 

These pages provides somes webinars for vaccinology courses
This area is only available in English

Safety of COVID-19 Vaccines


Discussion topic:
Safety of COVID-19 Vaccines
There will be two main presentations as follows:

COVID-19 Vaccine Safety – Perspective from WHO’s Global Advisory Committee on Vaccine Safety
Presenter: Rita Helfand, Chair, Global Advisory Committee on Vaccine Safety, WHO, and Senior Advisor for Science, National Center for Emerging and Zoonotic Infectious Diseases, CDC

COVID-19 Vaccine Safety – US experience
Presenter: Tom Shimabukuro, Acting Director, Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, CDC

Chair: Melinda Wharton, Associate Director for Vaccine Policy, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention (CDC) and Member of the ADVAC Scientific Committee

COVID vaccines – is there a need for boosters in view of the emergence of variants and waning immunity? (S4)



Discussion topic:
Vacunas contra el COVID: ¿Hay necesidad de refuerzos en vista de la aparición de nuevas variantes y la disminución de la inmunidad?
Session 4 (en español)

Presidente: Professor Romina Libster, Fundación INFANT, Argentina y profesora del ADVAC


Disertantes:
Professor Cristiana Toscano, Federal University of Goiás, Brazil
Evidencia para orientar la decisión sobre los esquemas de refuerzos de la vacunación contra COVID-19 ¿Qué sabemos y qué no sabemos?

Professor Celia Alpuche, Instituto Nacional de Salud Publica, Mexico
Desafíos y complejidades en el proceso de toma de decisiones para la vacunación COVID-19: experiencia de América Latina

Discusion:
Professor Alejandro Cravioto, Universidad Nacional Autónoma de México y Presidente del SAGE


COVID vaccines – is there a need for boosters in view of the emergence of variants and waning immunity? (S3)


Discussion topic:
COVID vaccines – is there a need for boosters in view of the emergence of variants and waning immunity?
Session 3 : 17:00-19:00 - (english)

Chair: Professor Anna Durbin, Johns Hopkins Bloomberg School of Public Health, USA and Member of the ADVAC Scientific Committee


Presenters:
Dr Jakob Cramer, Coalition for Epidemic Preparedness Innovations (CEPI), London, UK
Booster versus 2+1 primary immunisation vaccination: Does it matter?

Professor Stanley Plotkin, University of Pennsylvania, USA
Correlates of Protection as Indicators for Third Doses of COVID Vaccines

COVID vaccines – is there a need for boosters in view of the emergence of variants and waning immunity? (S2)


Discussion topic:
Vaccins COVID - est-il nécessaire de procéder à des rappels compte tenu de l'émergence de variants et de la baisse de l'immunité dans le temps?
Session 2 : 14:00-16:00 - (en français)

Président: Prof. Paul-Henri Lambert, Université de Genève et Membre du comité scientifique d’ADVAC


Orateurs:
Dre Christiane Eberhardt et Prof. Arnaud Didierlaurent, Université de Genève
Pour quoi, pour qui et pour quand? La 3ème dose du vaccin COVID-19 en question !

COVID vaccines – is there a need for boosters in view of the emergence of variants and waning immunity? (S1)


Discussion topic:
COVID vaccines – is there a need for boosters in view of the emergence of variants and waning immunity?
Session 1 : 10:00-12:00 - (english)

Chair: Dr Hanna Nohynek, National Institute for Health and Welfare, Helsinki, Finland and Member of the ADVAC Scientific Committee


Presenters:
Dr Jakob Cramer, Coalition for Epidemic Preparedness Innovations (CEPI), London, UK
Booster versus 2+1 primary immunisation vaccination: Does it matter?

Dr Jerome Kim, International Vaccine Institute, Seoul, Republic of Korea
The booster in your future: when, what, and why?


Will the success of mRNA vaccine development platforms for COVID-19 lead to new platforms for old vaccines?


Discussion topic:
Will the success of mRNA vaccine development platforms for COVID-19 lead to new platforms for old vaccines?
There will be two main presentations as follows:

The Immunological benefits of mRNA and potential applications
Presenter:  Barney Graham, previously with the National Institute of Health, USA

Regulatory approaches:  Issues and challenges, and questions to be asked by regulators
Presenter:  Philip Krause, Food & Drug Administration, USA

Dr Martin Friede, WHO will chair the meeting.


Logistics of deployment of COVID vaccines on a global level


Discussion topic:
Logistics of deployment of COVID vaccines on a global level  - how vaccines will make it to the most vulnerable populations 
Presenters:
Professor Lisa Cooper, Johns Hopkins Bloomberg School of Public Health
Dr Katherine O’Brien, WHO
Chairs:
Professor Anna Durbin, John Hopkins Bloomberg School of Public Health
Dr Emily Erbelding, NIAID/National Institutes of Health, USA.